Login / Signup

The additive value of patch testing non-commercial test substances and patients' own products in a clinic of occupational dermatology.

Kristiina Aalto-KorteMaria Pesonen
Published in: Contact dermatitis (2022)
We would have missed 39 (18.9%) of our 206 OACD cases if we had solely used commercial test substances.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • drinking water
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes